Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1225)
PRECISION BIOSCIENCES INC (DTIL)
Germano Geno J — Director
Shares
2,609
Price
$6.28
Total Value
$16.38K
Shares Held After
47,492
% of Holdings
5.5%
PRECISION BIOSCIENCES INC (DTIL)
Brown Melinda — Director
Shares
1,135
Price
$6.27
Total Value
$7.12K
Shares Held After
45,481
% of Holdings
2.5%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
1,083
Price
$154.88
Total Value
$167.74K
Shares Held After
70,818
% of Holdings
1.5%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
229
Price
$154.24
Total Value
$35.32K
Shares Held After
71,901
% of Holdings
0.3%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
136
Price
$152.71
Total Value
$20.77K
Shares Held After
72,130
% of Holdings
0.2%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
167
Price
$151.70
Total Value
$25.33K
Shares Held After
72,266
% of Holdings
0.2%
MANNKIND CORP (MNKD)
Binder Steven B. — Director
Shares
39,051
Price
$3.29
Total Value
$128.48K
Shares Held After
713,258
% of Holdings
5.2%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,176
Price
$99.60
Total Value
$216.73K
Shares Held After
736,048
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
3,121
Price
$200.54
Total Value
$625.89K
Shares Held After
39,765
% of Holdings
7.3%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
3,324
Price
$98.87
Total Value
$328.63K
Shares Held After
733,872
% of Holdings
0.5%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
27,000
Price
$98.69
Total Value
$2.66M
Shares Held After
314,209
% of Holdings
7.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
632
Price
$478.95
Total Value
$302.70K
Shares Held After
324,443
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,648
Price
$478.18
Total Value
$788.04K
Shares Held After
325,075
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,280
Price
$477.19
Total Value
$610.81K
Shares Held After
326,723
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,744
Price
$476.13
Total Value
$1.31M
Shares Held After
328,003
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,613
Price
$475.28
Total Value
$766.62K
Shares Held After
330,747
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
543
Price
$474.15
Total Value
$257.46K
Shares Held After
332,360
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$472.89
Total Value
$378.31K
Shares Held After
332,903
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$471.84
Total Value
$94.37K
Shares Held After
333,703
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$470.56
Total Value
$18.82K
Shares Held After
333,903
% of Holdings
0.0%
Damora Therapeutics, Inc. (DMRA)
Jarrett Jennifer — Director
Shares
12,500
Price
$20.23
Total Value
$252.88K
Shares Held After
512,500
% of Holdings
2.4%
CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Oei Khing Djien — Director
Shares
168,750
Price
$3.92
Total Value
$661.50K
Shares Held After
0
% of Holdings
100.0%
1225 transactions